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Abstract
THE EFFECT OF A PUFA DIET ON 
HUMAN RED BLOOD CELL LEVELS OF 2,3-DPG
by Sandra A. Dassenko
Fasting blood was collected at weekly intervals
and the level of 2,3-DPG of the red blood cell was
determined in 15 male subjects age 28 to 57 with serum
A lacto-cholesterol levels greater than 250 mg%. 
vegetarian diet containing no cholesterol, a high level 
of dietary fiber and a P/S ratio of 4.0 was provided for
28 days.
During the course of the experimental period 
the 2,3-DPG increased by an average of 0.83>*«moles/ml 
red blood cell which was highly significant (p^.001). 
This significant increase of 2,3-DPG which relates to 
an increased oxygen delivery capability of the red blood 
cells would indicate the benefit of this type of diet 
to the individual with a high risk of heart disease.
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2,3-diphosphoglycerate was first discovered in pig
erythrocytes in 1925 and later its presence was noted also
in the red cells of humans and in other mammals (Torrance,
Over four decades after its discovery, it was found 
that 2,3-diphosphoglycerate decreased the oxygen affinity 
of hemoglobin and apparently through this mechanism the 
oxygen delivery capacity of hemoglobin is regulated (Chanutin 
and Curnish, 1967? Benesch and Benesch, 1967).
Erythrocytes are unique in having the highest con-
1974) .
centration of 2,3-diphosphoglycerate (2,3-DPG) of any
About 76% of the organic phosphate intissue in the body, 
the erythrocytes is found as 2,3-DPG while other tissues
The molar concentrationhave about one-tenth of this amount.
of 2,3-DPG is about the same as that of hemoglobin found in
Other phosphates having similar effects 
on the oxygen dissociation characteristics of hemoglobin are 
ATP and pyridoxal phosphate which are present in smaller 
quantities (White et al., 1973; Torrance, 1974).
the red blood cell.
Formation of 2,3-DPG
In the Embden-Meyerhof pathway, the Rapoport- 
Luebering cycle is a shunt that leads to the production of 
2,3-DPG (see figure 1) from the intermediate of glycolysis.
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Embden-Meyerhof pathway showing Rapoport- 
Luebering cycle (Torrance, 1974).
Figure 1.
HK, hexokinase; G6P, glucose-6-phosphate;Abbreviations used:
GPI, phosphoglucose isomerase; F6P, fructose-6-phosphate; 
PFK, phosphofructokinase; F16DP, fructose-1,6-diphosphate; 
DHAP, dihydroxy acetone phosphate; TPI, triosephosphate 
isomerase; G3P, glyceraldehyde-3-phosphate; PGD, phospho- 
glycerate dehydrogenase; 1,3-DPG, 1,3-diphosphoglycerate; 
PGK, phosphoglycerate kinase; 3PG, 3-phosphoglycerate; DPG 
mutase, diphosphoglycerate mutase; 23 DPG, 2,3-diphospho- 
glycerate; DPG phosphatase, diphosphoglycerate phosphatase; 
Pi, inorganic phosphate; PGM, phosphoglycerate mutase; 2PG 
2-phosphoglycerate; PEP, phosphoenol pyruvate; PK, pyruvate 
kinase; LDH, lactate dehydrogenase; ATP, ADP, adenosine 
triphosphate and adenosine diphosphate; NAD, niacin adenine 
dinucleotide.
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In the red blood cell about1973) .1,3-DPG (White et al • r
20% of the glycolytic flux is normally via the formation of
2,3-DPG (Gerlach and Duhm, 1972; Torrance, 1974). The
enzyme diphosphoglycerate mutase (DPG mutase) is responsible 
for the formation of 2,3-DPG from 1,3-DPG while a diphospho­
glycerate phosphatase (DPG phosphatase) enzyme catalyzes 
the conversion of 2,3-DPG to 3-phosphoglycerate (3-PG). 
the two enzymes regulating synthesis and degradation of 
2,3-DPG, the DPG mutase is suggested as being more important, 
since the DPG phosphatase is less active (Rose, 1970;
Of
Gerlach and Duhm, 1972).
Control of 2,3-DPG Concentrations
The rate of 2,3-DPG synthesis and decomposition
controls the concentration of 2,3-DPG in the red blood cell.
The decomposition of 2,3-DPG is principally influenced by
a decrease in pH which activates the DPG phosphatase to
form 3-PG and inorganic phosphate. Alternately an increase
in 3-PG concentration inhibits the DPG phosphatase enzyme
activity (Gerlach and Duhm, 1972; Torrance, 1974).
The rate of synthesis of 2,3-DPG is controlled
principally by the 1,3-DPG level (Torrance, 1974). 
levels of 1,3-DPG are in turn regulated primarily by the
The
pH and by the inorganic phosphate (Pi) concentration
(Gerlach and Duhm, 1972; Torrance, 1974). This effect
of pH is mediated through the PFK and PGD enzyme catalyzed
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steps with an increase of pH serving as a stimulus to
Since inorganic phosphate is required 
by the PGD enzyme catalyzed reaction the concentration of 
Pi available can also control the level of red blood cell
these reactions.
Other factors that control glycolysis such as1,3-DPG.
NAD/NADH and ATP/ADP ratios also will influence the
quantity of 2,3-DPG produced (Gerlach and Duhm, 1972;
Rapoport et al, 1972).
The rate of synthesis of 2,3-DPG is controlled by
2,3-DPG serves as an inhibitorits own concentration also.
of DPG mutase (Rose, 1970; Williamson et al, 1970). As
more oxygen is bound to hemoglobin, more 2,3-DPG becomes 
free thus inhibiting the mutase and hemoglobin release of 
oxygen to the tissues is altered (Brewer, 1974). 
diffusable anions of 2,3-DPG then shift the hydrogen ions
The non-
A rise of nondiffusable freeout of the red blood cell.
2,3-DPG in the red cell decreases the intracellular pH
which decreases the rate of glycolysis, inhibits the mutase 
and thereby decreases 2,3-DPG levels (Rouault, 1973;
Gerlach and Duhm, 1972).
Role of 2,3-DPG in Oxygen Binding
The binding of 2,3-DPG to hemoglobin increases the 
oxygen availability to the tissues by reducing the oxygen 
affinity of the hemoglobin (Klocke, 1972). Deoxyhemoglobin 
binds 2,3-DPG near the center of the molecule through salt
5
bridges which are believed to form on the beta chains
between N-terminal amino groups (Arnone, 1974; Torrance,
Arnone (1974) further suggests the amino acid1974).
residues involved are histidine, lysine, and valine. After
oxygenation the configuration of hemoglobin changes and the 
binding of 2,3-DPG is more difficult (Klocke, 1972).
(1967) suggests that 2,3-DPG aids in regulating the allo-
Benesch
stearic properties of hemoglobin and by this means the 
oxygen affinity of the hemoglobin can be controlled.
The level of 2,3-DPG in the cell affects the binding
of oxygen to hemoglobin and the oxygen dissociation curve. 
A shift to the right is noted in the oxygen dissociation 
curve (ODC) when 2,3-DPG is increased (see figure 2, curve
C). This shift facilitates the delivery of oxygen to the
When 2,3-DPG istissues (Rouault, 1973; Harkness, 1971).
absent or low at a given pC>2 the ODC shifts to the left so 
that more oxygen is bound to the hemoglobin but less is 
released to the tissues (see figure 2, curve A). A shift 
of the ODC to the left releases less oxygen to the tissues 
than when there is a rightward shift (Torrance, 1974).
By altering the affinity of hemoglobin for oxygen, 
the level of 2,3-DPG adapts to conditions of hypoxia. A 
change in 2,3-DPG levels was first noted in individuals 
when there was an altitude change. The red blood cells 
of people living at high altitudes have higher levels of 
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PO2 mm Hg
Normal, high and low levels of 2,3-DPG effect on the oxygen 
dissociation curve.
Figure 2.
(Adampted from Torrance, 197*0
A = low level of 2,3"DPG 
B * normal level of 2,3"DPG 
C = high level of 2,3“DPG
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those living at sea level (Eaton et al., 1969; Harper,
1973) . Astrup (1970) indicates the1973; White et al • r
change in 2,3-DPG at high altitudes is caused by a small
Thus there is a fine line balance betweenchange in pH.
pH and 2,3-DPG.
Although the hypoxic condition was first noted at 
high altitude, the occurrence of hypoxia is not limited 
to high altitude conditions. In anemia, pulmonary disease, 
impaired cardiac function and other disease states where 
oxygen release to the tissues is impaired, a hypoxia 
condition exists (Woodson et al., 1970; Brewer and Eaton,
Decreased oxygen availability to the tissues is 
compensated for by an increase in red blood cell glycolysis 
and a rise in 2,3-DPG levels which results in a rightward
1971).
shift in the oxygen dissociation curve (Woodson et al..
1970; Rouault, 1973; Brewer et al., 1972; Brewer and Eaton,
1971).
Relationship of 2,3-DPG to Hypoxia and Cardiovascular
Disease
Research suggests that the arteriosclerotic changes 
noted in rabbits are brought about by hypoxic conditions
1969; Garbarsch et al1968; Helin et al(Kjeldsen et al • f• r• r
More recent research indicates changes related to 
arteriosclerosis contribute to the hypoxic condition
1969).
1972; Gainer and Chisholm, 1974) . In(Chisholm et al • t
high cholesterol red blood cell membranes are thicker and
8
would have greater resistance and be a barrier to oxygen
availability to the tissues with a shift to the left of
1974). Papahadjopoulos (1974)the ODC (Steinbach et al • /
also states even a small increase in concentration of
cholesterol in membranes will affect permeability.
The hypoxia hypothesis linked with increased risk
of coronary artery disease associates elevated serum 
cholesterol with preventing the release of oxygen to the
tissues (Brewer, 1972; Brewer, 1974). The change in
oxygen carrying capacity in coronary artery disease causes 
a decreased oxygen availability to the tissues and may 
increase the risk of arteriosclerosis (Brewer, 1974; Colvard
and Longmuir, 1973).
Purpose of Study
It has been proposed that arteriosclerosis develops 
as a consequence of insufficient transport of oxygen to the 
arterial intimal tissues (Gainer and Chisholm, 1974; Brewer,
Since 2,3-DPG levels in the red blood cells relate1974) .
to the oxygen delivery capability of the red blood cells, 
it seemed desirable to determine the effect of a dietary
program which is known to reduce the risk of coronary heart 
disease, upon the red blood cell level of 2,3-DPG. 
male subjects with cholesterol levels greater than 250 mg% 
were given a lacto-vegetarian diet high in polyunsaturated 





Fifteen male subjects were selected from a community
heart attack risk program. The individuals were selected on
the basis of age, cholesterol level and willingness to 
participate in the scientific study. Age of the men ranged 
from 28 to 57 with cholesterol levels 250 mg% and above.
All fifteen individuals participated in the study the entire
28 days.
The men were served three meals a day seven days a 
week during the four week research study. The morning and 
evening meals were served in the Nutrition Research Kitchen. 
After breakfast each morning the subjects were given a
prepared sack lunch for the noon meal.
A research laboratory in the Nutrition Department
was arranged to collect blood samples by a medical tech-
Each Sunday morning betweennologist and a physician, 
seven and eight am* the subjects had a fasting blood sample 
Breakfast was served immediately after the blooddrawn.
drawing.
Diet
The individuals were provided a lacto-vegetarian 
diet during the 28 day study. Polyunsaturated/saturated
9
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fat ratio, cholesterol level and fiber content were
Less than 35% of thespecifically altered in the diet, 
daily caloric intake was fat with the polyunsaturated/
saturated (P/S) fat ratio of 4.0. The main sources of 
fat included a polyunsaturated corn oil margarine, liquid 
corn oil and vegetarian meat analogs. No significant
source of cholesterol in foods was provided and an egg
substitute was used for breakfast and baking.
Fiber was included in the diet at 10 grams per
Foods high in fiber such as fresh fruit and vegetables.day.
whole grain breads and cereals and textured vegetable
protein (TVP) were used. An additional amount of fiber
was added in the form of bran to cereal or entree or des-
(Seesert to increase the amount of fiber on some days.
appendix for approximate composition of daily menu.)
The menu for the 28 days was a 7 day cycle (See
appendix). The first week began with day one menu and
subsequent weeks with day two menu, day three menu and day
No meal was the same for any given day eachfour menu.
Once a week a buffet supper with a specific culturalweek.
theme was served.
The individuals were not restricted on total food
intake except for desserts, maintaining weight (not gaining 
or losing more than five pounds during the study). The
individuals ate all the meals from the food provided. Water
No alcohol was to be consumed during thewas not limited.
study.
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Each day's diet was adequate in the RDA of nutrients 
and no supplementation was given. A computerized nutrient
analysis was computed from USDA Handbook #8.
DPG Determination
The procedure for determining 2,3-DPG in the 
erythrocyte followed instructions in a kit by CalBiochem,
La Jolla, California (see appendix). The kit was developed 
based on the method of Nygaard and Rorth (1969). The test 
kit worked with "2,3-DPG as an essential rate determining
co-factor in the conversion of 3-PG to 2-PG catalyzed by
PGM. The 2-PG formed is subsequently converted into PEP 
by enolase. PEP reacts with ADP in the presence of PK to 
yield pyruvate and ATP. The pyruvate is then reduced to 
lactate by LDH; simultaneously, a molar equivalent quantity 
of NADH is oxidized. The rate of change in absorbance at
340 nm is proportional to the concentration of 2,3-DPG in
the sample".
Fasting blood was collected in tubes containing 
After mixing the blood specimen and 
anticoagulant by inversion the specimen was placed in an
Immediately the capillary pack cell
A 0.1 ml sample of 
blood was diluted with 9.9 ml of distilled water and mixed
anticoagulant EDTA.
ice-water bath.
volume was determined by hematocrit.
The diluted sample was then placed in an iced waterwell.
Thebath for five minutes for hemolysis to occur.
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hemolysate was then frozen and stored with the analysis 
being made within three days after collection, 
time limit for storage of hemolysate in the frozen state is
(Recommended
one week.)
The reagent from the kit was reconstituted, refrig­
erated and used within the six hour limit for the storage
time. A hemolysate sample was removed from the freezer 
and allowed to thaw until only a small amount of ice 
remained then placed in a 30° C. water bath to warm. A 
pipette was used to dispense 3.0 ml of reagent into a 
clean, dry test tube. The reagent was then placed in the 
constant-temperature waterbath to bring the reagent to
the required temperature. After the sample and reagent 
reached 30° C 0.1 ml of sample was added to the reagent.• >
This was mixed thoroughly by inversion then approximately 
3.0 ml of sample-reagent mixture was transferred imme­
diately to a clean dry cuvet which had also been in the 
constant-temperature waterbath. After drying the cuvet, 
it was promptly placed into the temperature controlled 
cell compartment of the photometer. An initial absorbance 
was read approximately two minutes after placing the cuvet 
in the instrument. A timer was simultaneously started
and exactly four minutes after the initial reading the
Using water as a blank all 
measurements were made in the photometer at 340 nm and
final absorbance was read.
30° C.
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The change in absorbance was obtained by sub­
tracting the final absorbance from the initial value, 




A(4 minutes) x N x PCV x D
where
A A = change in absorbance in 4 minutes
2.5
N = a conversion factor AA (for 4 minutes)
where 2.5 = equivalent concentration of
standard in undiluted whole blood
PCV = value of the hematocrit in percent of
packed red blood cells
D = dilution factor which was 1 as 100
microliters of sample was used
RESULTS AND DISCUSSION
A lacto-vegetarian diet which was high in poly­
unsaturated fat (P/S ration 4.0) and high in dietary fiber 
(10 grams fiber/day) was fed to 15 male subjects who had 
serum cholesterol levels greater than 250 mg% for a period 
of 28 days. Weekly blood samples were drawn and the 2,3-DPG 
was determined. A significant rise in levels of 2,3-DPG 
was noted (p ^.001) between an initial blood sample and 
after 28 days on a lacto-vegetarian diet (see figure 3).
The average rise in 2,3-DPG levels during the study was 
0.83 yM.moles/ml red blood cell with an initial average 
reading of 4.45 ^moles/ml red blood cells to a final 
reading of 5.28 ^moles/ml red blood cells. Arturson et al. 
(1974) and Bunn et al. (1974) suggest levels from 4.67 to 
5.0 >umoles/ml red blood cells. During the same time 
period a significant decrease in cholesterol levels was 
observed (p^.001) (see figure 4). The average decrease 
in cholesterol during the time was 78 mg%. Complete data
The 2,3-DPG andreported elsewhere (Johnson, 1975) . 
cholesterol data were analyzed using computer program
BMDX64 (Dixon, 1969) having 2,3-DPG as the dependent
variable with week and Cholesterol as covariables.
Cholesterol was also analyzed as the dependent variable
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Figure 3. Mean 2,3-DPG levels in /imoles/ml red blood 
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suggest that the relationship between 2,3-DPG and choles­
terol is not causal but the changes in both are related to
The dietary fat and fiber content weretime 01^ the diet, 
the only changes in life style that the subjects experienced.
For this reason these dietary changes are regarded as the
cause for the observed changes in 2,3-DPG.
A change in dietary lipids affect the type of 
lipids found in the plasma which are in a dynamic equilib­
rium with lipids in the erythrocyte membrane (Tarlov, 1966;
A change in typeLondon and Schwarz, 1953; Reed, 1968).
and level of plasma lipids would then change the erythrocyte
In 1968 and again in 1970, De Gier foundmembrane lipids.
the permeability of liposome membranes was influenced by
the fatty acid composition. The liposome membrane was
also shown to be affected by cholesterol which reduced
permeability (Demel et al., 1968; De Gier et al., 1969). 
Papahadjopoulos (1974) suggests the level of cholesterol 
in membranes controls the fluidity and structure with a 
more stable structure decreasing permeability and electrical
Increased amounts of cholesterol contributeconductivity.
to a more stable structure and can inhibit membrane enzymes
and reduce the transport rate of ions. The prediction is
that a small increase in membrane cholesterol may greatly
effect permeability. This hypothesis is supported by
Steinbach et al. (1974) whose data showed that high blood
cholesterol levels lowered red blood cell oxygen saturation
18
in rabbits, which was interpreted as relating to a reduction 
of oxygen transport across the red cell membrane. These 
reported changes in membrane transport may explain the in­
crease in red blood cell 2,3-DPG in response to changes 
in dietary lipids. Thus the observations in this study 
may relate to a change in glucose transport across the
red blood cell membrane.
Additional studies relating to the activity of the
DPG mutase and DPG phosphatase enzymes may also account
A change in pH mayfor the change in levels of 2,3-DPG. 
be suggested for further study because as pH changes, the 
rate of glycolysis, the activity of the enzymes and level
of 2,3-DPG is altered.
In subjects with a high risk of heart disease, 
the increased availability of oxygen for the tissues 
possibly brought about by an increase in the level of 
2,3-DPG would be beneficial.
SUMMARY
Fifteen men ages 28 to 57 with a serum cholesterol 
greater than 250 mg% were given a lacto-vegetarian diet
The diet had a P/S ratio of 4.0, no choles­
terol containing foods and included a high level of fiber.
The blood (fasting) was collected at weekly inter­
vals and the 2,3-DPG level of the red blood cell was
for 28 days.
During the course of the experimental period
At the end of the experi-
determined.
the 2,3-DPG increased with time, 
mental period, 2,3-DPG had increased by an average of 0.83 
^mole/ml of red blood cell which was highly significant 
This significant increase of 2,3-DPG which 
relates to an increased oxygen delivery capability of the 
red blood cells would indicate the benefit of this type
(p<.001).
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AVERAGE COMPOSITION OF A DAILY MENU
2500Average calories
35%Percent of calories from fat
14%Percent of calories from protein
51%Percent of calories from carbohydrate
10 grams 
insignificant




A SEVEN-DAY LACTO-VEGETARIAN MENU 
FOR CHOLESTEROL LOWERING STUDY

























Cashew Nut Loaf 
Mashed potatoes/gravy 
Carrots







Tossed salad/Fr. or It. 
Dressing
Fresh fruit plate
DAY 3 DAY 4
Breakfast
Orange juice









































































Fruit over toast 











f 29Each day's menu also includedOrange juice for breakfast Non fat milk 






Low fat cheese 
Fresh fruit




EFFECT OF DIET ON LEVEL OF 2,3-DPG IN MOLES/ML 
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Calbiochem reagents for the quantitative measurement of 2,3-diphosphoglycerate (2,3-DPG) in 
erythrocytes are of high quality. Each reagent is prepared from components of specified purity which 
have met Calbiochem's stringent quality control standards. They are formulated in accordance with 
current good manufacturing practices.
Calbiochem's 2,3-DPG reagents are based on the method of Nygaard and Rorth (1). The concen­
trations of the reactants have been changed in the optimization of the reagent. This optimization has 
resulted in a lower level of 3-phosphoglyceric acid, LDH, enolase anc phosphoglyceromutase in the 
reagent, and a reduction in the blank rate. A rate assay was selected over the stoichiometric procedure 
described by Rose and Liebowitz (2) as the rate assay is virtually specific, has a low blank, eliminates 
preparation of a protein-free filtrate, requires less sample and shorter working time. The method re­
quires the assay of a standard and the use of a photometer capable of measuring absorbance changes 
at 340 nm.
Among the most important physiological properties of hemoglobin (Hb) is being an oxygen carrier 
in erythrocytes. Hemoglobin's ability to release oxygen into the environmental tissues during the lim­
ited time the erythrocytes are in the tissue capillaries may be evaluated by 2,3-DPG assays.
A knowledge of the effect the erythrocytes' enzymatic constituents have on this property is of vital 
importance (3, 4, 5, 6).
Normal erythrocytes of humans and other mammals contain 2,3-DPG in a molar concentration 
comparable to hemoglobin. It has been recently shown that 2,3-DPG can be bound on an equimolar 
basis with deoxyhemoglobin (7). In the resulting complex, the affinity of hemoglobin for oxygen is 
lower than hemoglobin in a salt-free solution. As a result, in the presence of a sufficient amount of 
2,3-DPG, the release of oxygen by hemoglobin to the tissue is facilitated. However, stored blood, in 
which the level of 2,3-DPG has decreased below a critical point, has a high oxygen affinity and is thus 
unable to release oxygen to the tissues. This blood is of little benefit to the critically ill patient.
2.3- Diphosphoglycerate is the phosphate compound present in largest concentration (3.5 /iM/ml) 
in the normal human erythrocytes, where it contributes approximately one-third of the total organic 
phosphorus. The disappearance of this metabolite during blood bank storage is the first and most sig­
nificant index of a decline in the viability of erythrocytes.
Erythrocytes depleted of 2,3-DPG during storage will, following transfusion regenerate significant 
amounts of the metabolites, but only after a clinically significant time. This regeneration will occur in 
the same cells after a relatively short period of incubation with ribonucleosides. Similarly, in cells 
stored in ACD solution containing inosine, the level of 2,3-DPG is maintained for a longer period than 
in ACD alone (4,8, 7).
2.3- DPG acts as a readily available store against which the cell can draw to satisfy critical metabol­
ic requirements. The concentration of 2,3-DPG increases in response to decreased environmental oxy­
gen tension. Thus, in individuals moving from a low to a high altitude, the level of 2,3-DPG rises. 
After strenuous muscular exercise and in conditions associated with hypoxia, e.g., obstructive pul­
monary emphysema, chronic pulmonary disease, right to left cardiac shunt, severe anemia and thyro­
toxicosis, etc., the level of 2,3-DPG is increased (8, 9, 10). Patients with erythrocytes deficient in 







PEP + ADP Pyruvate + ATP
LDH
Pyruvate + NADH Lactate + NAD
Abbreviations:











In this reaction, 2,3-DPG is an essential rate determining co-factor in the conversion of 3-PG to 
2-PG catalyzed by PGM. The 2-PG formed is subsequently converted into PEP by enolase. PEP reacts 
with ADP in the presence of PK to yield pyruvate and ATP. The pyruvate is then reduced to lactate 
by LDH; simultaneously, a molar equivalent quantity of NADH is oxidized. The rate of change in 












IfVial contents may be under vacuum, 
there is any indication moisture has penetrated 
the seal, discard the vial in question.
For In Vitro Diagnostic Use
"A" vials (reagent), when reconstituted ac­
cording to instructions, will yield a solution 
containing approximately 
Tris buffer 0.1 moles/liter 











8.7 x 10~3 moles/liter RECONSTITUTION OF THE 
REAGENTS
2000 I U/liter 
2000 I U/liter 
167 I U/liter
A. Stat-Pack™ (Cat. No. 869237)
1. Reconstitute the contents of one of the 
B vials (cofactor) with 15.5 ml of dis­
tilled water. Cap and invert genf/y.
2. Open one of the A vials and transfer the 




"B" vials (cofactor), when reconstituted ac­
cording to instructions, will yield approximately 
1.9 x 10_^moles/liter
STORAGE AND STABILITY
Unopened vials are stable for at least 12 
months when stored between 2° and 8°C. The 
reconstituted and combined reagent A and B is 
stable for at least 6 hours when stored in a glass 




“2,3-0 iphosphoglycerateStandard” contains 
250 /imoles/dl2,3-DPG
©Copyright 1974 by Calbiochem.
Reproduction, in part or whole, only with our permission.
-2-
If evidence of bacterial contamination ap­
pears, discard the solution.
If the well-mixed reagent shows an initial ab­
sorbance measured against distilled water of less 
than 0.7 at 340 nm, consider the reagent un­
suitable for 2,3-DPG assay and discard.
Dilute 1 volume of cells with 199 volumes 
of distilled water (1:200 dilution). Mix well 
by inversion and store frozen until use. De­
termine the hematocrit of the packed cells 
for use in the calculations.
2. An alternative procedure is to centrifuge the 
sample in a calibrated capillary tube using a 
microhematocrit centrifuge. After reading 
the hematocrit, the capillary tube can be cut 
at the interface between white cells and red 
cells. Dilute 1 volume of packed cells with 
199 volumes of distilled water (1:200 dilu­
tion) . M ix well by inversion and store frozen 
until use.
SPECIMEN COLLECTION AND PREPA­
RATION FOR ANALYSIS
Preparation of the Hemolysate
1. The blood may be collected in most of the 
commonly employed anticoagulants: EDTA, 
heparin, oxalates and ACD (acid-citrate- 
dextrose) can be used. Blood collected in 
fluorides (e.g. Vacutainer® grey-stoppered 
tubes) cannot be used in this assay. Blood 
collected in ACD solution may be stored at 
4°C. Since the 2,3-DPG levels in blood 
change rapidly after collection, prepare the 
hemolysate without undue delay.
2. Mix the blood specimen and anticoagulant 
by inversion. Determine the hematocrit by 
any accurate technique for use in the calcu­
lations. Dilute 0.1 ml of blood with 9.9 ml 
of distilled water (1:100 dilution) and mix 
well. As most 2,3-DPG is found in the eryth­
rocytes, a 1:100 dilution virtually eliminates 
the possibility of interfering contaminants 
owing to their extremely low concentrations 
in the diluted sample.
3. Place the diluted specimen in an iced water- 
bath for 5 minutes.
4. Store hemolysate frozen until assayed. He- 
molysates of whole blood or packed red 
cells can be stored frozen for at least a week 
without loss of 2,3-DPG. If samples are to 
be stored for a longer period, prepare a per­
chloric acid protein-free filtrate. Dilute 1 
volume of well-mixed blood with 4 volumes 
of 0.6 M perchloric acid (5.15 ml of 70% 
perchloric acid diluted to 100 ml with dis­
tilled water). Mix well. Let stand for 5 min­
utes; centrifuge for 5 minutes at 3000 RPM. 
Dilute 1 volume of the supernatant with 19 
volumes of distilled water. Final dilution is 
1:100.
Alternate Procedure
Hemolysates can also be prepared from
packed red cells by one of the following
procedures:
1. Cool blood in an iced waterbath. Centri­
fuge for at least 15 minutes at 3000 RPM. 
Withdraw the plasma, leukocytes and the 
top part of the red cells. Mix the cells well.
INTERFERING SUBSTANCES
To test the sample for interfering substances, 
assay the sample and a standard separately and 
then combined. If no interfering substances are 
present, the total 2,3-DPG assayed in the mix­
ture will equal the sum of the sample plus the 
standard.
Fluoride at concentrations used in blood col­
lecting tubes will interfere with this assay.
PREPARATION OF THE PATIENT




Vial A — 2,3-DPG Reagent (buffer, enzyme, 
substrate)
Vial B — NADH (cofactor)
2,3-DPG Standard
Reagents Not Supplied




Dissolve and bring to a final volume of 100 ml. 
Use 1.2 ml of this solution for 5 ml of blood.
Material Required But Not Provided
1. A photometer capable of reading absorbance 
changes at 340 nm.
2. Constant-temperature waterbath or device 
for controlling temperature at 30°C.
3. Suitable matched cuvets with a known light 
path.
4. Class A volumetric pipets, or similarly accu­
rate dispensing devices, for measuring the vol­






5. M icropipets, or similarly accurate devices, ca­
pable of delivering 0.100 ml (100 jlil) or less. 
The accuracy should be 0.008 ml/ml.
6. Timer
7. To prepare reagent solutions use only highly 
purified distilled or deionized water, free of 




A standard solution containing 2.5 jdmoles 
of 2,3-DPG per ml of solution (250/Xmoles/dl) 
is supplied with every package. This solution 
can be used to standardize the procedure in the 
laboratory. Calbiochem recommends that a de­
termination of the factor "N" be included in 
each batch of test specimens run. In addition, a 
complete calibration curve should be deter­
mined at periodic intervals to insure linearity 
of response over the entire range of the test 
with the instrument used.
1. Determination of Factor N: Dilute 1 vol­
ume of the standard with 99 volumes of dis­
tilled water. This gives a solution containing 
25 nanomoles of 2,3-DPG per ml of solution 
(equivalent to the concentration of 2,3-DPG 
in a 1:100 dilution of whole blood contain­
ing 2.5 jUmoles 2.3-DPG/ml). Assay the 
diluted standard following steps 1-6 under 
"Assay". Calculate the factor "N" from the 
formula:
TEMPERATURE FACTORS
The absorbance change of the sample and 
of the standard must be measured at the same 
temperature.
At temperatures below 22°C, the reaction 
rate may be too slow while above 37°C, the 
enzymes may be inactivated. Use 30°C, if 
possible.
ASSAY
Depending on the technical equipment avail­
able, specimen/assay volume ratios may vary.
1. Using a suitable pipet, dispense 3.0 ml of the 
prepared reagent into a clean, dry cuvet.
2. Using water as a blank, make all measure­
ments at 340 nm.
3. Place the cuvets in a constant-temperature 
waterbath for 3 minutes or as long as needed 
to bring the reagent to the established tem­
perature. Preincubate the sample for the 
same length of time in the same bath. Cal­
biochem recommends this test be performed 
at 30°C.
4. Add 0.100 ml (100 microliters) of sample to 
the cuvet. Mix quickly by gentle inversion 
with a square of Parafilm® over the mouth 
of the cuvet. Avoid shaking as this can trap 
air bubbles in the solution. Wipe the cuvet 
dry and immediately insert into the tempera­
ture controlled cell compartment of the pho­
tometer. A constant temperature must be 
maintained while obtaining assay values.
5. Read the initial absorbance (Aq) approxi­
mately 2 minutes after placing the cuvet in 
the instrument. Simultaneously, start a 
timer.
6. Exactly 4 minutes after the initial reading, 
determine the final absorbance (A4).
7. If the absorbance change of a sample is more 
than twice that observed for the standard, re­
peat the test using less sample. Use dilution 
factor D (see ifel under 'Calculation') to com­
pensate for the dilution.
2.5
N =
Aa (for 4 minutes) 
where N = calibration factor, 2.5 = equiva­
lent concentration of standard in undiluted 
whole blood, and Aa (for 4 minutes) = the 
absorbance change observed for the diluted 
standard solution.
2. Calibration Curve. To construct a calibra­
tion curve corresponding to the original val­
ues for whole blood before dilution, dilute 
the standard as follows: Original
Blood
ValueStandard Water
1 volume + 249 volumes = 1 /tmol/ml
1 volume + 99 volumes = 2.5 /imol/ml 
1 volume + 49 volumes = 5^mol/ml 
Assay the diluted standards according to the 
test procedure. Plot on graph paper the con­
centration of the standard versus the cor­
responding Aa for 4 minutes. This curve 
may not pass through the origin.
QUALITY CONTROL
Hemolysates of whole blood, packed red 
blood cells (both of which can be stored frozen 
for one week) or a perchloric acid, protein-free 
filtrate (which can be stored frozen for periods 
longer than one week) should be analyzed daily 
along with the samples. To prepare the protein- 
free filtrate, dilute 1 volume of well-mixed blood 
with 4 volumes of 0.6M perchloric acid (5.15 ml
-4-
using 100 microliters of sample (D = 1), N = 
9.7, hematocrit = 41% and with 1:100 he- 
molysate dilution:
Aa (for 4 minutes) = 0.770 - 0.510 = 0.260 
Then:
0.260 x9.7 6.15 ,Umoles 2,3-DPG/ml
red blood cells.
Calculation for Alternate Procedure #1
of 70% perchloric acid diluted to 100 ml with 
distilled water). Mix well. Let stand for 5 min­
utes; centrifuge for 5 minutes at 3000 RPM. 
Dilute 1 volume of the supernatant with 19 vol­
umes of distilled water to obtain a final dilution 
of 1:100.
Daily quality control should fall within 2 
standard deviations of the established value. If 
the precision of the assay system does not cor­
relate with this standard and repetition excludes 
errors in technique, check the following areas:
1. Cleanliness of glassware, especially cuvets.
2. Purity of water (deionization is good if water 
has a conductivity of 1 jUMHOS or less).
3. Instrument wavelength setting, light source 
and absorbance calibration.
4. Reaction temperature, including temperature 
control systems.
5. Pipetting and timing mechanisms.
6. Expiration date of the reagent package and 
the reconstituted reagents.
7. Storage conditions of reconstituted reagents.
Aa (for 4 minutes) x N x 2 x ^ x D -
/Imole 2,3-DPG/ml red blood cells. 
Calculation for Alternate Procedure $2 
Aa (for 4 minutes) x N x 2 x D = /Jmole 
2,3-DPG/ml red blood cells.
LIMITATIONS
When determining values in highly active 
specimens, altering the assay volumes may be 
necessary. Departures from the recommended 
specimen/assay volume ratio will necessitate 
changes in the calculation factor.CALCULATION
For a 1:100 dilution of whole blood, the 2,3- 
DPG concentration in /Umoles per ml of red
blood cells = Aa (for 4 minutes) x N x x D.
Aa is the observed change in absorbance in the 
4-minute period. N is the conversion factor, de­
termined empirically for each reconstituted re­
agent as stated in "Standardization,” PC V is the 
value of the hematocrit in percent of packed red 
blood cells and D is a dilution factor.
1. To obtain Aa, the change in absorbance, 
subtract the final absorbance (A4) from the 
initial absorbance (A0):
Aa (for 4 minutes) = A0 - A4.
2. If the reaction is too fast or too slow, use re­
spectively more or less sample. The actual 
amount of sample used determines the dilu­
tion factor D as follows:
D = 1, when 100 microliters of sample are 
used.
D = 1.97, when 50 microliters of sample are 
used.
D = 0.52, when 200 microliters of sample 
are used.
If D is other than 1, multiply the answer by 
this dilution factor.
3. Calculation example (in/tmoles 2,3-DPG/ml 
red blood cells):
When A0 = 0.770 and A4 = 0.510 at 30°C
EXPECTED VALUES
Calbiochem recommends each laboratory es­
tablish its own recovery values suitably repre­
sentative of the "normal" range for the assay. 
The range of expected values determined for 
2,3-DPG in apparently healthy human specimens 
is reported to be from 3 to 4.4 /Umole/ml red 
blood cells (1).
PERFORMANCE
Assuming the minimum absorbance change 
which can be measured is 0.004 in 4 minutes (N 
equals 9.7 and the hematocrit is 41%), the sen­
sitivity of the method would be 0.09 /imoles of 
2,3-DPG/ml red blood cells.
It has been found that the diluted sample 
does not contain substances at concentrations 
high enough to interfere with the assay (7). 
Since the assay is sensitive to slight variations in 
some of the reaction parameters, it is necessary 
to standardize each reagent when it is recon­
stituted.
Duplicate assays on an abnormal control 
yielded a coefficient of variation of 3%.
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